Jiangsu Hengrui | 600276 - Cash And Equivalent


Jiangsu Hengrui reported CNY40.36B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Sh Fosun Pharma CNY 11.48B 1.48B Sep/2025
Sh Pharmaceutical CNY 36.73B 2.36B Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Wuxi Apptec CNY 29.44B 7.95B Sep/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025